Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
55.83
+0.04 (0.07%)
At close: Feb 21, 2025, 4:00 PM
56.00
+0.17 (0.30%)
After-hours: Feb 21, 2025, 7:53 PM EST
BMY Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 48,300 | 45,006 | 46,159 | 46,385 | 42,518 | Upgrade
|
Revenue Growth (YoY) | 7.32% | -2.50% | -0.49% | 9.09% | 62.62% | Upgrade
|
Cost of Revenue | 11,949 | 10,518 | 10,137 | 9,940 | 11,773 | Upgrade
|
Gross Profit | 36,351 | 34,488 | 36,022 | 36,445 | 30,745 | Upgrade
|
Selling, General & Admin | 7,865 | 7,678 | 7,777 | 7,655 | 7,618 | Upgrade
|
Research & Development | 9,782 | 9,112 | 9,509 | 10,195 | 10,048 | Upgrade
|
Operating Expenses | 26,519 | 25,837 | 26,881 | 27,873 | 27,354 | Upgrade
|
Operating Income | 9,832 | 8,651 | 9,141 | 8,572 | 3,391 | Upgrade
|
Interest Expense | -1,958 | -1,161 | -1,205 | -1,303 | -1,381 | Upgrade
|
Interest & Investment Income | 478 | 449 | 171 | 39 | 121 | Upgrade
|
Earnings From Equity Investments | 44 | -38 | -108 | 231 | 72 | Upgrade
|
Currency Exchange Gain (Loss) | 31 | 160 | 148 | 32 | 23 | Upgrade
|
Other Non Operating Income (Expenses) | 1,481 | 2,119 | 1,827 | 1,708 | 1,528 | Upgrade
|
EBT Excluding Unusual Items | 9,908 | 10,180 | 9,974 | 9,279 | 3,754 | Upgrade
|
Merger & Restructuring Charges | -1,968 | -893 | -520 | -724 | -1,255 | Upgrade
|
Gain (Loss) on Sale of Investments | -28 | -122 | -693 | 514 | 1,157 | Upgrade
|
Gain (Loss) on Sale of Assets | -15 | - | 211 | 9 | 55 | Upgrade
|
Asset Writedown | -2,819 | -107 | - | - | - | Upgrade
|
Legal Settlements | -84 | -10 | -178 | -82 | 194 | Upgrade
|
Other Unusual Items | - | 305 | -266 | 261 | 1,757 | Upgrade
|
Pretax Income | -8,379 | 8,440 | 7,713 | 8,098 | -6,871 | Upgrade
|
Income Tax Expense | 554 | 400 | 1,368 | 1,084 | 2,124 | Upgrade
|
Earnings From Continuing Operations | -8,933 | 8,040 | 6,345 | 7,014 | -8,995 | Upgrade
|
Minority Interest in Earnings | -15 | -15 | -18 | -20 | -20 | Upgrade
|
Net Income | -8,948 | 8,025 | 6,327 | 6,994 | -9,015 | Upgrade
|
Net Income to Common | -8,948 | 8,025 | 6,327 | 6,994 | -9,015 | Upgrade
|
Net Income Growth | - | 26.84% | -9.54% | - | - | Upgrade
|
Shares Outstanding (Basic) | 2,027 | 2,069 | 2,130 | 2,221 | 2,258 | Upgrade
|
Shares Outstanding (Diluted) | 2,027 | 2,078 | 2,146 | 2,245 | 2,258 | Upgrade
|
Shares Change (YoY) | -2.45% | -3.17% | -4.41% | -0.58% | 31.89% | Upgrade
|
EPS (Basic) | -4.41 | 3.88 | 2.97 | 3.15 | -3.99 | Upgrade
|
EPS (Diluted) | -4.41 | 3.86 | 2.95 | 3.12 | -3.99 | Upgrade
|
EPS Growth | - | 30.85% | -5.45% | - | - | Upgrade
|
Free Cash Flow | 13,942 | 12,651 | 11,948 | 15,234 | 13,299 | Upgrade
|
Free Cash Flow Per Share | 6.88 | 6.09 | 5.57 | 6.79 | 5.89 | Upgrade
|
Dividend Per Share | 2.420 | 2.310 | 2.190 | 2.010 | 1.840 | Upgrade
|
Dividend Growth | 4.76% | 5.48% | 8.96% | 9.24% | 9.52% | Upgrade
|
Gross Margin | 75.26% | 76.63% | 78.04% | 78.57% | 72.31% | Upgrade
|
Operating Margin | 20.36% | 19.22% | 19.80% | 18.48% | 7.98% | Upgrade
|
Profit Margin | -18.53% | 17.83% | 13.71% | 15.08% | -21.20% | Upgrade
|
Free Cash Flow Margin | 28.87% | 28.11% | 25.88% | 32.84% | 31.28% | Upgrade
|
EBITDA | 19,407 | 18,420 | 19,423 | 19,329 | 13,824 | Upgrade
|
EBITDA Margin | 40.18% | 40.93% | 42.08% | 41.67% | 32.51% | Upgrade
|
D&A For EBITDA | 9,575 | 9,769 | 10,282 | 10,757 | 10,433 | Upgrade
|
EBIT | 9,832 | 8,651 | 9,141 | 8,572 | 3,391 | Upgrade
|
EBIT Margin | 20.36% | 19.22% | 19.80% | 18.48% | 7.98% | Upgrade
|
Effective Tax Rate | - | 4.74% | 17.74% | 13.39% | - | Upgrade
|
Revenue as Reported | 48,300 | 45,006 | 46,159 | 46,385 | 42,518 | Upgrade
|
Advertising Expenses | 1,500 | 1,400 | 1,300 | 1,300 | 990 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.